| Title |
Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) consensus on the usage of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
|
|---|---|
| Published in |
The Egyptian Heart Journal, May 2020
|
| DOI | 10.1186/s43044-020-00058-0 |
| Pubmed ID | |
| Authors |
Ashraf Reda, Ahmed Shawky Elserafy, Elsayed Farag, Tamer Mostafa, Nabil Farag, Atef Elbahry, Osama Sanad, Ahmed Bendary, Ahmed Elkersh, Mohammed Selim, Morad Beshay, Hazem Khamis |
Mendeley readers
The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 24 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 8 | 33% |
| Other | 3 | 13% |
| Student > Ph. D. Student | 2 | 8% |
| Lecturer | 1 | 4% |
| Professor | 1 | 4% |
| Other | 3 | 13% |
| Unknown | 6 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 33% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 8% |
| Nursing and Health Professions | 2 | 8% |
| Biochemistry, Genetics and Molecular Biology | 2 | 8% |
| Immunology and Microbiology | 1 | 4% |
| Other | 1 | 4% |
| Unknown | 8 | 33% |